CA2405604A1 - Inhalateur nasal - Google Patents
Inhalateur nasal Download PDFInfo
- Publication number
- CA2405604A1 CA2405604A1 CA002405604A CA2405604A CA2405604A1 CA 2405604 A1 CA2405604 A1 CA 2405604A1 CA 002405604 A CA002405604 A CA 002405604A CA 2405604 A CA2405604 A CA 2405604A CA 2405604 A1 CA2405604 A1 CA 2405604A1
- Authority
- CA
- Canada
- Prior art keywords
- chamber
- adapter
- interior
- container
- nasal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000126 substance Substances 0.000 claims abstract description 85
- 210000003928 nasal cavity Anatomy 0.000 claims abstract description 25
- 238000004891 communication Methods 0.000 claims abstract description 23
- 238000000034 method Methods 0.000 claims abstract description 9
- 210000001331 nose Anatomy 0.000 claims description 46
- 239000000463 material Substances 0.000 claims description 8
- 239000007922 nasal spray Substances 0.000 claims description 5
- 229940097496 nasal spray Drugs 0.000 claims description 5
- 239000003570 air Substances 0.000 description 41
- 239000000443 aerosol Substances 0.000 description 11
- 239000007921 spray Substances 0.000 description 9
- 239000012528 membrane Substances 0.000 description 7
- 230000036961 partial effect Effects 0.000 description 7
- 238000007906 compression Methods 0.000 description 5
- 230000006835 compression Effects 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 210000003811 finger Anatomy 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000000241 respiratory effect Effects 0.000 description 4
- 210000001944 turbinate Anatomy 0.000 description 4
- 206010028748 Nasal obstruction Diseases 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 239000000850 decongestant Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 206010039083 rhinitis Diseases 0.000 description 3
- 210000003813 thumb Anatomy 0.000 description 3
- 206010027654 Allergic conditions Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 208000019695 Migraine disease Diseases 0.000 description 2
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 229940124581 decongestants Drugs 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000000492 nasalseptum Anatomy 0.000 description 2
- 229940124583 pain medication Drugs 0.000 description 2
- 208000036273 reactive airway disease Diseases 0.000 description 2
- 201000009890 sinusitis Diseases 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000000592 Nasal Polyps Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- -1 for example Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 229940071648 metered dose inhaler Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000008518 non respiratory effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
L'invention concerne un inhalateur nasal destiné à l'administration d'une substance dans la cavité nasale d'un utilisateur. Cet inhalateur nasal est composé d'une chambre comprenant une partie intérieure et une partie extérieure, une sortie comprenant un passage d'air et communicant avec l'intérieur de la chambre, ainsi qu'une entrée de dosage en communication avec l'intérieur de la chambre. Un contenant, comprenant une partie de distribution, est placé dans l'entrée de dosage. Dans un mode de réalisation préféré, un adaptateur définissant un passage d'entrée est relié à la chambre. Un masque peut également être connecté à la sortie. Un mode d'administration de la substance dans la cavité nasale de l'utilisateur consiste à introduire la sortie dans la cavité nasale, à introduire la substance dans la chambre et à l'inhaler par la sortie. L'invention concerne également un mode d'assemblage de cet inhalateur nasal.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93434600A | 2000-04-14 | 2000-04-14 | |
| US60/197,779 | 2000-04-14 | ||
| PCT/IB2001/000617 WO2001078818A2 (fr) | 2000-04-14 | 2001-04-12 | Inhalateur nasal |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2405604A1 true CA2405604A1 (fr) | 2001-10-25 |
Family
ID=25465392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002405604A Abandoned CA2405604A1 (fr) | 2000-04-14 | 2001-04-12 | Inhalateur nasal |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP1311314A2 (fr) |
| CA (1) | CA2405604A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119607335B (zh) * | 2020-03-24 | 2025-11-25 | 苏州新劢德医疗器械科技有限公司 | 一种鼻喷雾递送装置 |
| CN115192836B (zh) * | 2022-06-30 | 2024-02-02 | 深圳市美大嘉业科技有限公司 | 一种智能温控吸入式电子鼻烟壶 |
-
2001
- 2001-04-12 CA CA002405604A patent/CA2405604A1/fr not_active Abandoned
- 2001-04-12 EP EP01921705A patent/EP1311314A2/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1311314A2 (fr) | 2003-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6644305B2 (en) | Nasal inhaler | |
| US9352106B2 (en) | Particle dispersion device for nasal delivery | |
| US4796614A (en) | Collapsible inhalation valve | |
| JP4578689B2 (ja) | エーロゾル薬物供給装置及び方法 | |
| EP1450885B1 (fr) | Nebuliseur nasal | |
| US3490452A (en) | Therapeutic face mask | |
| US7841337B2 (en) | Breath-actuated nasal delivery device | |
| US7832393B2 (en) | Spacer/holding chamber for pressurized metered dose inhaler | |
| US6595206B2 (en) | Extendable spacer device and metered dose inhaler | |
| US20080066743A1 (en) | Aerosol medication delivery apparatus with narrow orifice | |
| US6539939B2 (en) | Multi-function oral breathing support system | |
| EP1673123A2 (fr) | Pulverisateur integre et chambre de dispersion de particules en vue d'une administration nasale d'un medicament dans les fosses nasales profondes et les sinus de la face | |
| JPH0141343B2 (fr) | ||
| CN111214735B (zh) | 一种雾化器储雾罐 | |
| JP7182561B2 (ja) | ネブライザ用スペーサ装置 | |
| US20070074718A1 (en) | Metered dose inhaler having spacing device | |
| US7465287B2 (en) | Apparatus for dispensing powdered material | |
| CA2405604A1 (fr) | Inhalateur nasal | |
| CN112827042A (zh) | 一种适用于肺部疾病治疗的输氧面罩 | |
| GB2378176A (en) | Apparatus for dispensing powdered material | |
| US20080190420A1 (en) | Aerosol Medication Delivery Apparatus | |
| CN121001772A (zh) | 肺部药物输送装置 | |
| JPH09168592A (ja) | 医薬吸入器の携帯用アダプター | |
| JPH0565348U (ja) | 薬剤ディスペンサーとともに使用する伸縮自在な分散室 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |